1. Home
  2. MGLD vs QTTB Comparison

MGLD vs QTTB Comparison

Compare MGLD & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MGLD

The Marygold Companies Inc.

N/A

Current Price

$1.20

Market Cap

44.8M

Sector

Finance

ML Signal

N/A

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$5.70

Market Cap

44.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGLD
QTTB
Founded
1996
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.8M
44.3M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
MGLD
QTTB
Price
$1.20
$5.70
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$13.00
AVG Volume (30 Days)
13.6K
359.5K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
136.78
EPS
N/A
2.42
Revenue
$34,876,734.00
$53,737,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$2.33
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$1.38
52 Week High
$1.38
$8.05

Technical Indicators

Market Signals
Indicator
MGLD
QTTB
Relative Strength Index (RSI) 49.48 46.53
Support Level $0.86 $5.51
Resistance Level $1.36 $6.37
Average True Range (ATR) 0.08 0.93
MACD -0.00 -0.18
Stochastic Oscillator 39.28 4.73

Price Performance

Historical Comparison
MGLD
QTTB

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is an international holding company focused on acquiring and growing profitable businesses. Its main segments include U.S. Fund Management through USCF Investments, Food Products via Gourmet Foods and Printstock Products in New Zealand, Beauty Products under the Original Sprout brand, and formerly Security Systems through Brigadier, sold in 2025. The majority of revenue comes from fund management. The company operates in the USA, New Zealand, the United Kingdom, and Canada, with the majority of revenue generated from the USA. Its business approach focuses on strengthening financial services, expanding fintech, and managing a diverse portfolio for growth.

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.

Share on Social Networks: